February 16, 2022 – Inari Medical, Inc. has announced that the first patient has been enrolled in PEERLESS, a prospective, randomized controlled trial comparing the outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the FlowTriever system versus

February 16, 2022 – The Heart Institute at Children’s Hospital Colorado (Children’s Colorado) has performed its 500th pediatric heart transplant, a milestone that only a few centers across the country have reached.

February 16, 2022 – A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart arrhythmia diagnosis in clinical practice — has debuted at UC San Diego Health.

February 16, 2022 – The Centers for Disease Control and Prevention estimate that someone in the United States has a stroke every 40 seconds. Hundreds of thousands of people each year are living with the long-term impacts caused by strokes — including partial paralysis, cognitive difficulties and persistent pain — with no consistently effective treatment options for improving their neurological conditions. 

February 16, 2022 – A revolutionary pacemaker that re-establishes the heart’s naturally irregular beat is set to be trialed in New Zealand heart patients this year, following successful animal trials. “Currently, all pacemakers pace the heart metronomically, which means a very steady, even pace.

February 15, 2022 — American Heart Association CEO Nancy Brown issued the following statement in response to the Senate confirmation of Robert M. Califf, M.D., as commissioner of the Food and Drug Administration (FDA):

February 15, 2022 – More than $625,000 in research grants devoted to congenital heart defects (CHD) were awarded today by the American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives, and The Children’s Heart Foundation, the nation’s leading organization dedicated to funding CHD research.

January 15, 2022 – Babies who are born with only one functioning heart ventricle must undergo a series of three surgeries to correct the problem. The final surgery establishes Fontan circulation, which reroutes the circulatory system. However, more than half of patients who undergo the procedure don’t live into adulthood. To reduce the negative health effects associated with the Fontan procedure, UCF researchers are developing a self-powered injection jet shunt that uses the heart’s own energy to alleviate the heightened internal pressure caused by the rerouted circulatory system.

February 15, 2022 – Vivalink, a leading provider of digital healthcare solutions, has announced the results of a company survey focused on clinicians’ use of Holter monitors versus mobile cardiac telemetry (MCT).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now